FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976632546> ?p ?o ?g. }

• W1976632546 endingPage "21800" @default.
• W1976632546 startingPage "21797" @default.
• W1976632546 abstract "Unlike normal mammalian cells, which use oxygen to generate energy, cancer cells rely on glycolysis for energy and are therefore less dependent on oxygen. We previously observed that the c-Myc oncogenic transcription factor regulates lactate dehydrogenase A and induces lactate overproduction. We, therefore, sought to determine whether c-Myc controls other genes regulating glucose metabolism. In Rat1a fibroblasts and murine livers overexpressing c-Myc, the mRNA levels of the glucose transporter GLUT1, phosphoglucose isomerase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and enolase were elevated. c-Myc directly transactivates genes encoding GLUT1, phosphofructokinase, and enolase and increases glucose uptake in Rat1 fibroblasts. Nuclear run-on studies confirmed that the GLUT1 transcriptional rate is elevated by c-Myc. Our findings suggest that overexpression of the c-Myc oncoprotein deregulates glycolysis through the activation of several components of the glucose metabolic pathway. Unlike normal mammalian cells, which use oxygen to generate energy, cancer cells rely on glycolysis for energy and are therefore less dependent on oxygen. We previously observed that the c-Myc oncogenic transcription factor regulates lactate dehydrogenase A and induces lactate overproduction. We, therefore, sought to determine whether c-Myc controls other genes regulating glucose metabolism. In Rat1a fibroblasts and murine livers overexpressing c-Myc, the mRNA levels of the glucose transporter GLUT1, phosphoglucose isomerase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and enolase were elevated. c-Myc directly transactivates genes encoding GLUT1, phosphofructokinase, and enolase and increases glucose uptake in Rat1 fibroblasts. Nuclear run-on studies confirmed that the GLUT1 transcriptional rate is elevated by c-Myc. Our findings suggest that overexpression of the c-Myc oncoprotein deregulates glycolysis through the activation of several components of the glucose metabolic pathway. carbohydrate response element hypoxia-inducible transcription factor glucose transporter 1 lactate dehydrogenase Dulbecco's modified Eagle's medium fetal bovine serum murine leukemia virus hydroxytamoxifen tamoxifen cycloheximide 2-deoxyglucose phosphofructokinase glyceraldehyde-3-phosphate dehydrogenase phosphoglucose isomerase phosphoglycerate mutase triose-phosphate isomerase hexokinase To form a three-dimensional multicellular spheroid mass, neoplastic cells alter their metabolism such that they are able to survive and grow in the hostile microenvironments created by the decreased blood flow found in tumor vasculature (1.Hemlinger G. Yuan F. Dellian M. Jain R.K. Nature Med. 1997; 3: 177-182Crossref PubMed Scopus (1372) Google Scholar, 2.Dang C.V. Semenza G.L. Trends Biochem. Sci. 1999; 24: 68-72Abstract Full Text Full Text PDF PubMed Scopus (927) Google Scholar). The most striking feature of tumor cells is the production of large amounts of lactic acid, which is due to the glycolytic conversion of glucose to lactic acid even in the presence of oxygen (3.Warburg O.H. Science. 1956; 123: 309-314Crossref PubMed Scopus (9809) Google Scholar). This is often accompanied by an increased rate of glucose transport (4.Pedersen P.L. Prog. Exp. Tumor Res. 1978; 22: 190-274Crossref PubMed Google Scholar, 5.Flier J.S. Mueckler M.M. Usher P. Lodish H.F. Science. 1987; 235: 1492-1495Crossref PubMed Scopus (692) Google Scholar, 6.Birnbaum M.J. Haspel H.C. Rosen O.M. Science. 1987; 235: 1495-1498Crossref PubMed Scopus (245) Google Scholar). Glucose is a major regulator of gene transcription. In particular, it stimulates transcription of genes encoding glycolytic and lipogenic enzymes in adipocytes and hepatocytes through the carbohydrate response element (ChoRE),1 a 5′-CACGTG-3′ motif (7.Jacoby D.B. Zilz N.D. Towle H.C. J. Biol. Chem. 1989; 264: 17623-17626Abstract Full Text PDF PubMed Google Scholar, 8.Foufelle F. Gouhot B. Pegorier J.P. Perdereau D. Girard J. Ferre P. J. Biol. Chem. 1992; 267: 20543-20546Abstract Full Text PDF PubMed Google Scholar, 9.Thompson K.S. Towle H.C. J. Biol. Chem. 1991; 266: 8679-8682Abstract Full Text PDF PubMed Google Scholar, 10.Lefrancois-Martinez A.M. Diaz-Guerra M.J. Vallet V. Kahn A. Antoine B. FASEB J. 1994; 8: 89-96Crossref PubMed Scopus (61) Google Scholar, 11.Towle H.C. J. Biol. Chem. 1995; 270: 23235-23238Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). The ChoRE is similar to the core binding site for the transcription factors USF2 (12.Vallet V.S. Casado M. Henrion A.A. Bucchini D. Raymondjean M. Kahn A. Vaulont S. J. Biol. Chem. 1998; 273: 20175-20179Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar), which is implicated in glucose metabolism, TFE3, and the hypoxia-inducible transcription factor (HIF). Hence, the ChoRE serves to integrate physiological signals through transcription factors to regulate glucose metabolism. During tumor formation, adaptation to hypoxia may be mediated by the HIF-1 family of transcription factors, which induce angiogenesis and other metabolic changes. (2.Dang C.V. Semenza G.L. Trends Biochem. Sci. 1999; 24: 68-72Abstract Full Text Full Text PDF PubMed Scopus (927) Google Scholar, 13.Semenza G.L. Roth P.H. Fang H.M. Wang G.L. J. Biol. Chem. 1994; 269: 23757-23763Abstract Full Text PDF PubMed Google Scholar, 14.Semenza G.L. Jiang B.H. Leung S.W. Passantino R. Concordet J.P. Maire P. Giallongo A. J. Biol. Chem. 1996; 271: 32529-32537Abstract Full Text Full Text PDF PubMed Scopus (1376) Google Scholar). It is notable that glucose transport and transporter mRNA are induced in cells transformed byras or src oncogenes (5.Flier J.S. Mueckler M.M. Usher P. Lodish H.F. Science. 1987; 235: 1492-1495Crossref PubMed Scopus (692) Google Scholar). The c-myconcogene is activated in a variety of pathways that are important in controlling cell growth and tumorigenesis. (15.He T.C. Sparks A.B. Rago C. Hermeking H. Zawel L. da Costa L.T. Morin P.J. Vogelstein B. Kinzler K.W. Science. 1998; 281: 1509-1512Crossref PubMed Scopus (4092) Google Scholar, 16.Barone M.V. Courtneidge S.A. Nature. 1995; 378: 509-512Crossref PubMed Scopus (283) Google Scholar, 17.Afar D.E. Goga A. McLaughlin J. Witte O.N. Sawyers C.L. Science. 1994; 264: 424-426Crossref PubMed Scopus (187) Google Scholar, 18.Dang C.V. Mol. Cell. Biol. 1999; 19: 1-11Crossref PubMed Scopus (1395) Google Scholar). Intriguingly, the ChoRE sequence matches the core E-box (5′-CACGTG-3′) binding site for c-Myc, which binds E-boxes of target genes to stimulate transcription (2.Dang C.V. Semenza G.L. Trends Biochem. Sci. 1999; 24: 68-72Abstract Full Text Full Text PDF PubMed Scopus (927) Google Scholar, 18.Dang C.V. Mol. Cell. Biol. 1999; 19: 1-11Crossref PubMed Scopus (1395) Google Scholar, 19.Grandori C. Eisenman R.N. Trends Biochem. Sci. 1997; 22: 177-181Abstract Full Text PDF PubMed Scopus (245) Google Scholar). Previous work showed that c-Myc directly up-regulates the expression of the lactate dehydrogenase gene (LDH-A) (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar), which is important in the transformed phenotype (anchorage-independent growth) of cells that overexpress c-Myc (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar, 21.Shim H. Chun Y.S. Lewis B.C. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 1511-1516Crossref PubMed Scopus (256) Google Scholar). In addition to LDH-A, we report here the deregulation of GLUT 1 and several glycolytic genes by c-Myc. Rat fibroblasts were cultured in 5% CO2 at 37 °C in DMEM supplemented with 10% fetal bovine serum (FBS; Life Technologies, Inc.) and antibiotics. Rat1a and Myc-transformed Rat1a-Myc fibroblasts were as described previously (22.Hoang A.T. Cohen K.J. Barrett J.F. Bergstrom D.A. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 6875-6879Crossref PubMed Scopus (196) Google Scholar). Human lymphoid cells were cultured in Iscove's modified Dulbecco's medium with 10% FBS and antibiotics. Cells lacking c-myc (HO15), heterozygous HET15, and parental lines (TGR) (a gift of John Sedivy, Brown University) were cultured in DMEM supplemented with 10% FBS and antibiotics (23.Mateyak M.K. Obaya A.J. Adachi S. Sedivy J.M. Cell. Growth Differ. 1997; 8: 1039-1048PubMed Google Scholar). HO15 cells were transfected with either MLVmyc or MLV empty vectors (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar) using Lipofectin (Life Technologies, Inc.) according to the manufacturer's protocol. The human GLUT1 cDNA (24.Mueckler M. Caruso C. Baldwin S.A. Panico M. Belch I. Morris H.R. Allard W.J. Lienhard G.E. Lodish H.F. Science. 1985; 229: 941-945Crossref PubMed Scopus (1149) Google Scholar) was kindly provided by Drs. M. Mueckler (Washington University, St. Louis, MO) and C. Heilig (The Johns Hopkins University, Baltimore, MD). A Rat1 cell line expressing a fusion protein of c-Myc and the human estrogen receptor (MycER) (a gift of J. M. Bishop, University of California, San Francisco) was grown in DMEM with 10% FBS, penicillin, and streptomycin (25.Littlewood T.D. Hancock D.C. Danielian P.S. Parker M.G. Evan G.I. Nucleic Acids Res. 1995; 23: 1686-1690Crossref PubMed Scopus (704) Google Scholar). Myc activity was induced when confluent MycER cells were treated with 0.25 μm 4-hydroxytamoxifen (4-HOTM; Research Biochemicals, Natrick, MA) for the times indicated as described (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar, 26.Grandori C. Mac J. Siebelt F. Ayer D.E. Eisenman R.N. EMBO J. 1996; 15: 4344-4357Crossref PubMed Scopus (187) Google Scholar). To block protein synthesis, 10 μmcycloheximide (CHX) was added to the cells 30 min prior to 4-HOTM treatment. Animal studies were approved by The Johns Hopkins University School of Medicine Animal Use and Care Committee. Adenoviral constructs (a gift from W. El-Deiry, University of Pennsylvania, Philadelphia, PA) containing either LacZ (Ad/LacZ) or c-myc (Ad/c-myc) coding sequence were as described (27.Mitchell K.O. El-Deiry W.S. Cell Growth & Differ. 1999; 10: 223-230PubMed Google Scholar). Two-month-old male BALB/c mice, weighing 20–25 g, were intravenously injected with 4 × 109plaque-forming units (pfu) of either Ad/LacZ or Ad/c-myc. Mice were then sacrificed by exposure to CO2 on days 3, 4, and 5 after viral injection. Their livers were quickly removed and processed for RNAs or frozen in liquid nitrogen. Total RNA was isolated by guanidium thiocyanate lysis followed by cesium chloride centrifugation. 15-μg aliquots of RNA were used in Northern blot analysis (22.Hoang A.T. Cohen K.J. Barrett J.F. Bergstrom D.A. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 6875-6879Crossref PubMed Scopus (196) Google Scholar). IMAGE Consortium cDNA clones (28.Iyer N.V. Kotch L.E. Agani F. Leung S.W. Laughner E. Wenger R.H. Gassmann M. Gearhart J.D. Lawler A.M. Yu A.Y. Semenza G.L. Genes Dev. 1998; 12: 149-162Crossref PubMed Scopus (2068) Google Scholar) were obtained (Research Genetics, Inc.), and the inserts were isolated and 32P-labeled by Random-Primer synthesis using a Random-PrimeII kit (Stratagene). Nuclear run-on assays were performed as described (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar, 29.Groudine M. Peretz M. Weintraub H. Mol. Cell. Biol. 1981; 1: 281-288Crossref PubMed Scopus (439) Google Scholar). Nuclei were isolated from nonadherent cells (2 × 107) and incubated with buffered [32P]UTP (500 μCi), and labeled RNAs were isolated after treatment with DNase, proteinase K incubation, and phenol-chloroform extraction. Labeled RNAs (1.2 × 107cpm) from either Rat1a-Myc or Rat1a cells were hybridized at 42 °C for 40 h with membrane slot-blotted with denatured glucose transporter 1 and vimentin cDNA fragments. Uptake experiments were conducted on confluent Rat1a and MycER cells. Cells were treated with 0.25 μm 4-HOTM (Research Biochemicals, Natrick, MA) 1 h before 0.1 mm 2-DG with 10 nm [3H]2-DG (final concentration) were added. At the end of a 10-min incubation, cells were washed with ice-cold phosphate-buffered saline. Cells were than lysed by the addition of 2 ml of 10 mm NaOH containing 0.1% Triton X-100, and a 100-μl aliquot was assayed for 3H by liquid scintillation counting (30.Yu N. Maciejewski-Lenoir D. Bloom F.E. Magistretti P.J. Mol. Pharmacol. 1995; 48: 550-558PubMed Google Scholar). The protein content was measured by the method of Bradford (31.Bradford M.M. Anal. Biochem. 1976; 72: 248-254Crossref PubMed Scopus (217544) Google Scholar). To identify genes whose expression is deregulated in the presence of increased ectopic c-Myc, c-Myc-transformed Rat1a cells were studied (Fig. 1 A). Using this system of isogenic cell lines, GLUT1, phosphofructokinase (PFK), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglucose isomerase (GPI), phosphoglycerate mutase (PGM), and enolase showed elevated mRNA levels in c-Myc-transformed cells as compared with the nontransformed Rat1a cells. The expression levels of aldolase A, aldolase C, and triose-phosphate isomerase (TPI) were decreased, and the expression levels of hexokinase I, hexokinase II, and phosphoenolpyruvate carboxykinase were unchanged. Rat vimentin was used as a control (32.Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (135) Google Scholar). To determine whether c-Myc could induce GLUT1 and glycolytic gene expression in vivo, we injected adenoviruses expressing either LacZ or c-Myc into mice. Tail-vein injection of adenoviruses has the advantage of very high hepatic clearance, which yields highly efficient gene delivery to the liver (33.Ferry N. Heard J.M. Hum. Gene Ther. 1998; 9: 1975-1981Crossref PubMed Scopus (80) Google Scholar). Four days after injection, 40% of hepatocytes were positive for β-galactosidase in LacZ adenovirus-treated animals (data not shown). 2S. Kim, Q. Li, C. V. Dang, and A. Lee, unpublished observations. c-Myc protein levels were 10-fold elevated in Myc adenovirus-treated animals (Fig.1 B). GLUT1, PFK, GAPDH, PGM, and enolase mRNAs were significantly induced in the Myc-expressing livers as compared with LacZ-expressing livers at 4 and 5 days after injection of viruses (Fig.1 C). These observations suggest that transient expression of Myc in vivo induces hepatic expression of the same glycolytic genes that are induced in the Rat1a system. To determine whether the genes displaying increased or decreased levels of mRNA expression are transcriptionally activated by Myc, we used a previously described Rat1 fibroblast line expressing a protein that fuses Myc to the estrogen receptor ligand binding domain (MycER). With exposure of cells expressing the MycER protein to estrogenic compounds such as 4-hydroxytamoxifen (4-HOTM), the ligand-bound MycER protein translocates to the nucleus. The MycER protein then activates target genes without requiring new intervening protein synthesis (26.Grandori C. Mac J. Siebelt F. Ayer D.E. Eisenman R.N. EMBO J. 1996; 15: 4344-4357Crossref PubMed Scopus (187) Google Scholar, 34.Eilers M. Picard D. Yamamoto K.R. Bishop J.M. Nature. 1989; 340: 66-68Crossref PubMed Scopus (390) Google Scholar). Hence, prior exposure of MycER cells to the protein synthesis inhibitor cycloheximide (CHX) would not block activation or repression of direct target genes by 4-HOTM. Activation of MycER by 4-HOTM caused induction of GLUT1, PFK, and enolase mRNAs in the presence of CHX at 2 and 4 h (Fig. 2 A). Note that mRNA levels are diminished in the CHX + TM samples at the 6 h time point; this is likely due to decreased MycER protein (10% of 0 h level) with CHX treatment (data not shown). GAPDH, GPI, and PGM expression were not increased in the MycER system. Thus, GAPDH, GPI, and PGM do not meet this criterion for direct targets of c-Myc. Among the potentially down-regulated genes identified in Rat1a-Myc cells, only TPI mRNA moderately decreased in MycER cells exposed to 4-HOTM. However, a decrease in TPI mRNA was also seen with CHX treatment alone. The ribosomal phosphoprotein (36B4) mRNA level was shown to be unresponsive to estrogen and independent of cell cycle progression (35.Laborda J. Nucleic Acids Res. 1991; 19: 3998Crossref PubMed Scopus (434) Google Scholar, 36.Keyomarsi K. Pardee A.B. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 1112-1116Crossref PubMed Scopus (508) Google Scholar) and was therefore used as a control. To account for experimental variation, a separate tamoxifen induction experiment was performed, and GLUT1 expression in MycER cells was determined (Fig.2 B). Following c-Myc induction, GLUT1 expression behaves in a manner that is consistent with a direct c-Myc target. To determine whether 4-HOTM itself may directly increase the expression of GLUT1, PFK, and enolase independent of the MycER protein, we treated Rat1a cells lacking MycER with 4-HOTM, with or without CHX, and performed Northern analysis. The mRNA levels of these genes were unchanged upon addition of 4-HOTM and cycloheximide in the absence of the MycER protein (Fig. 2 C). Hence, the induction of enolase, GLUT1, and PFK expression in the Rat1a-MycER cells by 4-HOTM is dependent on MycER activity. To further authenticate GLUT1, PFK, and enolase as c-Myc targets, we sought to determine their expression in Rat1 fibroblasts lacking c-myc (Fig. 3). All three transcripts showed decreased levels in c-myc null cells as compared with wild type parental cells. The expression of PFK and enolase are elevated in c-myc null cells rescued by a constitutively overexpressed c-Myc (HO15-Myc) when compared with empty vector control transfected myc null cells (HO15-MLV). GLUT1 expression, however, was only slightly elevated in the c-Myc-overexpressing HO15 cells as compared with control MLV transfected cells, which display elevated GLUT1 as compared with the parental HO15 cells. Replicate experiments yielded similar results, in which the HO15-MLV cells have elevated expression of all three genes as compared with the HO15 parental cell line. The cause for this elevation in our control HO15-MLV cells is not known. Thus, in this genetically defined system Myc levels parallel the expression of these three target genes. Among the three up-regulated genes, GLUT1 is most frequently implicated in tumorigenesis (35.Laborda J. Nucleic Acids Res. 1991; 19: 3998Crossref PubMed Scopus (434) Google Scholar, 36.Keyomarsi K. Pardee A.B. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 1112-1116Crossref PubMed Scopus (508) Google Scholar, 37.Younes M. Lechago L.V. Somoano J.R. Mosharaf M. Lechago J. Cancer Res. 1996; 56: 1164-1167PubMed Google Scholar, 38.Younes M. Lechago L.V. Lechago J. Clin. Cancer Res. 1996; 2: 1151-1154PubMed Google Scholar). We therefore chose to characterize GLUT1 further. Nuclear run-on experiments demonstrated an enhanced transcriptional rate of GLUT1 in Rat1a-Myc cells as compared with Rat1a fibroblasts (Fig. 4 A). The nuclear run-on signals for enolase and PFK were low and insufficient for interpretation (not shown). These results, nevertheless, underscore the activation of GLUT1 by c-Myc at the transcriptional level. We further sought to determine whether GLUT1 expression parallels that of c-myc in Burkitt's lymphoma cells that are characterized by c-myc gene activation by chromosomal translocation. Both c-Myc-transformed lymphoblastoid (CB33-Myc) and Burkitt's lymphoma cell lines, Ramos and ST486, have elevated c-Myc protein levels (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar) that are associated with elevations of GLUT1 mRNA levels compared with the nontransformed lymphoblastoid CB33 cells (Fig. 4 B). We thus observed a correlation between c-Myc expression and the endogenous levels of GLUT1 mRNA in these Myc-transformed human lymphoid cells. To determine whether increased Myc activity influences glucose transport, [3H]2-DG uptake was studied in MycER Rat1 cells as well as Rat1a cells lacking the MycER system. 4-HOTM increased [3H]2-DG uptake in MycER cells, while it had no influence in Rat1a cells (Fig. 5). Normal mammalian cells use oxygen to generate energy from glucose and other metabolites through oxidative phosphorylation. In conditions of oxygen deprivation, normal cells rely on glycolysis to generate energy by converting glucose to lactic acid. Neoplastic transformation, however, alters glucose metabolism with enhanced conversion of glucose to lactic acid, thereby making tumor cells less dependent on oxygen. The molecular basis for physiological and pathological regulation of glucose metabolism is beginning to emerge with the identification of transcription factors that regulate glycolytic genes (2.Dang C.V. Semenza G.L. Trends Biochem. Sci. 1999; 24: 68-72Abstract Full Text Full Text PDF PubMed Scopus (927) Google Scholar). The ability of c-Myc, USF1, and HIF-1 transcription factors to regulate the LDH-A promoter through a Myc consensus binding site 5′-CACGTG-3′ suggests that these transcription factors converge onto commoncis elements (5′-RCGTG-3′) that are found in regulatory sequences of glycolytic genes (20.Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (869) Google Scholar). Because hypoxia physiologically induces glycolytic gene expression through HIF-1 binding sites, it stands to reason that glycolysis might also be activated by USF or c-Myc. Hence, we sought to determine whether c-Myc regulates genes that are also regulated by HIF-1. In this study, we observe that the glucose transporter GLUT1, PFK, GAPDH, GPI, PGM, and enolase are up-regulated by c-Myc in fibroblasts. In addition, we used adenovirus-mediated gene transfer to the liver as a means of studying in vivo gene expression and determined that these genes are also up-regulated by c-Myc in vivo. Our findings agree with a previous study of transgenic mice that also suggests the in vivo regulation of hepatic glycolysis by c-myc (41.Valera A. Pujol A. Gregori X. Riu E. Visa J. Bosch F. FASEB J. 1995; 9: 1067-1078Crossref PubMed Scopus (74) Google Scholar), although GLUT2, but not GLUT1, was induced in the transgenic livers. While our observation supports the hypothesis that c-Myc induces GLUT1 expression in the liver in vivo, the physiological significance of this induction is unclear because GLUT2 is the dominant form of hepatic glucose transporter. The use of transgenic mice, however, cannot establish whether c-Myc regulates certain genes directly. In our study, only GLUT1, PFK, and enolase behave as direct target genes in the MycER system. While some HIF-1 and c-Myc target genes overlap, the two sets of targets remain distinct. For example, the mRNA levels for HKI and adolase are unchanged or decreased by c-Myc, but are hypoxia inducible (2.Dang C.V. Semenza G.L. Trends Biochem. Sci. 1999; 24: 68-72Abstract Full Text Full Text PDF PubMed Scopus (927) Google Scholar, 13.Semenza G.L. Roth P.H. Fang H.M. Wang G.L. J. Biol. Chem. 1994; 269: 23757-23763Abstract Full Text PDF PubMed Google Scholar, 14.Semenza G.L. Jiang B.H. Leung S.W. Passantino R. Concordet J.P. Maire P. Giallongo A. J. Biol. Chem. 1996; 271: 32529-32537Abstract Full Text Full Text PDF PubMed Scopus (1376) Google Scholar). GPI is increased by c-Myc but is unaffected by hypoxia. Furthermore, we have reported that c-Myc overexpression down-regulates VEGF, a HIF-1-mediated hypoxia-inducible gene (42.Barr L.F. Campbell S.E. Diette G.B. Gabrielson E.W. Kim S. Shim H. Dang C.V. Cancer Res. 2000; 60: 143-149PubMed Google Scholar). We observed that c-Myc directly induces GLUT1 and increases glucose uptake in the Rat1 MycER cells. In addition to LDH-A, GLUT1 is an intriguing c-Myc target when its role in oncogenesis is considered (37.Younes M. Lechago L.V. Somoano J.R. Mosharaf M. Lechago J. Cancer Res. 1996; 56: 1164-1167PubMed Google Scholar,38.Younes M. Lechago L.V. Lechago J. Clin. Cancer Res. 1996; 2: 1151-1154PubMed Google Scholar). Elevation of GLUT1 and c-Myc RNA are among the earliest changes in gene expression after Ha-ras T24 transformation of Rat1a fibroblasts (39.Godwin A.K. Lieberman M.W. Mol. Carcinogenesis. 1991; 4: 275-285Crossref PubMed Scopus (9) Google Scholar). Reduction of GLUT1 expression through antisense GLUT1 RNA suppresses NIH 3T3 cell transformation by N-ras (40.Choi J.W. Yoon D.J. Lee H.W. Han D.P. Ahn Y.H. Yonsei Med. J. 1995; 36: 480-486Crossref PubMed Scopus (11) Google Scholar). Hence, the induction of GLUT1 expression by c-Myc may play an important role in tumor glucose metabolism. The specific roles of PFK and enolase in tumorigenesis are less clear. Glycolytic flux is controlled at multiple steps of glycolysis, such that interruption of a non-rate-limiting step may affect overall flux (43.Fell D.A. Biotechnol. Bioeng. 1998; 58: 121-124Crossref PubMed Scopus (115) Google Scholar). PFK is a rate-limiting glycolytic enzyme due to its intricate allosteric responses to ATP/ADP ratios and therefore may be critically important for the control of glycolytic flux. Enolase has not been directly implicated in human cancers; however, it is intriguing to note that a negative transactivating factor of the c-myc promoter (myc-binding protein 1) may be identical to enolase A (44.Chaudhary D. Miller D.M. Biochemistry. 1995; 34: 3438-3445Crossref PubMed Scopus (46) Google Scholar, 45.Subramanian A. Miller D.M. J. Biol. Chem. 2000; 275: 5958-5965Abstract Full Text Full Text PDF PubMed Scopus (233) Google Scholar). While the role for enolase in regulating c-mycexpression remains to be confirmed and further studied, this finding suggests that the induction of enolase by c-Myc may increase glycolysis and also serves as a negative feedback onto c-myc gene expression. In summary, we observe that while both c-Myc and HIF-1 up-regulates GLUT1 and glycolytic gene expression, the sets of target genes for these transcription factors are distinct. HIF-1 physiologically induces glycolytic gene expression in hypoxic cells that also undergo growth arrest. By contrast, c-Myc stimulates glucose uptake, glycolysis, and overall metabolism as well as activates the cell cycle machinery, which are all necessary for cell proliferation (46.Elend M. Eilers M. Curr. Biol. 1999; 28: R936-R938Abstract Full Text Full Text PDF Scopus (37) Google Scholar). The widespread deregulation of the c-myc gene in human cancers, therefore, may be a major contributor to the enhanced tumor glycolysis known as the Warburg effect, which may confer growth advantage to tumor cells deprived of oxygen. We thank Dr. G. L. Semenza for IMAGE Consortium glycolytic enzyme cDNA clones, Dr. W. El-Deiry for adenoviruses, and Dr. L. Gardner for comments." @default.
• W1976632546 created "2016-06-24" @default.
• W1976632546 creator A5000850685 @default.
• W1976632546 creator A5011561410 @default.
• W1976632546 creator A5035387431 @default.
• W1976632546 creator A5040256718 @default.
• W1976632546 creator A5042550448 @default.
• W1976632546 creator A5050244449 @default.
• W1976632546 creator A5053780153 @default.
• W1976632546 creator A5053850518 @default.
• W1976632546 creator A5058375431 @default.
• W1976632546 creator A5086720470 @default.
• W1976632546 date "2000-07-01" @default.
• W1976632546 modified "2023-10-16" @default.
• W1976632546 title "Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc" @default.
• W1976632546 cites W1503667331 @default.
• W1976632546 cites W1506002717 @default.
• W1976632546 cites W1521424334 @default.
• W1976632546 cites W1902193863 @default.
• W1976632546 cites W1966099909 @default.
• W1976632546 cites W1970252458 @default.
• W1976632546 cites W1971645561 @default.
• W1976632546 cites W1973754795 @default.
• W1976632546 cites W1999147603 @default.
• W1976632546 cites W1999334756 @default.
• W1976632546 cites W2002404925 @default.
• W1976632546 cites W2004583016 @default.
• W1976632546 cites W2007021266 @default.
• W1976632546 cites W2010394923 @default.
• W1976632546 cites W2011348663 @default.
• W1976632546 cites W2020790836 @default.
• W1976632546 cites W2025664777 @default.
• W1976632546 cites W2037872087 @default.
• W1976632546 cites W2037916432 @default.
• W1976632546 cites W2043605055 @default.
• W1976632546 cites W2058218780 @default.
• W1976632546 cites W2059617446 @default.
• W1976632546 cites W2063229165 @default.
• W1976632546 cites W2070147996 @default.
• W1976632546 cites W2072451938 @default.
• W1976632546 cites W2074783201 @default.
• W1976632546 cites W2077919719 @default.
• W1976632546 cites W2083091935 @default.
• W1976632546 cites W2086730539 @default.
• W1976632546 cites W2097774235 @default.
• W1976632546 cites W2098571898 @default.
• W1976632546 cites W2098972920 @default.
• W1976632546 cites W2100057506 @default.
• W1976632546 cites W2118749484 @default.
• W1976632546 cites W2139466117 @default.
• W1976632546 cites W2145059527 @default.
• W1976632546 cites W2162468227 @default.
• W1976632546 cites W2172103753 @default.
• W1976632546 cites W4293247451 @default.
• W1976632546 cites W94071839 @default.
• W1976632546 doi "https://doi.org/10.1074/jbc.c000023200" @default.
• W1976632546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10823814" @default.
• W1976632546 hasPublicationYear "2000" @default.
• W1976632546 type Work @default.
• W1976632546 sameAs 1976632546 @default.
• W1976632546 citedByCount "731" @default.
• W1976632546 countsByYear W19766325462012 @default.
• W1976632546 countsByYear W19766325462013 @default.
• W1976632546 countsByYear W19766325462014 @default.
• W1976632546 countsByYear W19766325462015 @default.
• W1976632546 countsByYear W19766325462016 @default.
• W1976632546 countsByYear W19766325462017 @default.
• W1976632546 countsByYear W19766325462018 @default.
• W1976632546 countsByYear W19766325462019 @default.
• W1976632546 countsByYear W19766325462020 @default.
• W1976632546 countsByYear W19766325462021 @default.
• W1976632546 countsByYear W19766325462022 @default.
• W1976632546 countsByYear W19766325462023 @default.
• W1976632546 crossrefType "journal-article" @default.
• W1976632546 hasAuthorship W1976632546A5000850685 @default.
• W1976632546 hasAuthorship W1976632546A5011561410 @default.
• W1976632546 hasAuthorship W1976632546A5035387431 @default.
• W1976632546 hasAuthorship W1976632546A5040256718 @default.
• W1976632546 hasAuthorship W1976632546A5042550448 @default.
• W1976632546 hasAuthorship W1976632546A5050244449 @default.
• W1976632546 hasAuthorship W1976632546A5053780153 @default.
• W1976632546 hasAuthorship W1976632546A5053850518 @default.
• W1976632546 hasAuthorship W1976632546A5058375431 @default.
• W1976632546 hasAuthorship W1976632546A5086720470 @default.
• W1976632546 hasBestOaLocation W19766325461 @default.
• W1976632546 hasConcept C104317684 @default.
• W1976632546 hasConcept C134018914 @default.
• W1976632546 hasConcept C149011108 @default.
• W1976632546 hasConcept C150194340 @default.
• W1976632546 hasConcept C161573976 @default.
• W1976632546 hasConcept C162324750 @default.
• W1976632546 hasConcept C185592680 @default.
• W1976632546 hasConcept C20251656 @default.
• W1976632546 hasConcept C2779306644 @default.
• W1976632546 hasConcept C34447519 @default.
• W1976632546 hasConcept C55493867 @default.
• W1976632546 hasConcept C62231903 @default.
• W1976632546 hasConcept C78780426 @default.

• next